CLAFORAN

This brand name is authorized in Brazil, Cyprus, Hong Kong, Ireland, Japan, Mexico, Singapore, Turkey

Active ingredients

The drug CLAFORAN contains one active pharmaceutical ingredient (API):

1 Cefotaxime UNII 258J72S7TZ - CEFOTAXIME SODIUM

Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis. Read about Cefotaxime

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DD01	Cefotaxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 502802602159314
Country: HK	Department of Health Drug Office	Identifier(s): 14614
Country: JP	医薬品医療機器総合機構	Identifier(s): 6132409D1050, 6132409D2056
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 239M80
Country: SG	Health Sciences Authority	Identifier(s): 01473P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809271203, 8699809271210, 8699809271227, 8699809271234, 8699809271241